SC 13G

Company

Cellectar Biosciences, Inc.

Filed

May 28, 2019

Accession Number

0001193125-19-158290

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →